Ticker brief
TSHA
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
14
authors 14d
8
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.42 (−1 bearish … +1 bullish)
Who spoke8
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Quantumup1 | C | -1.95 | 5 | +0.42 |
| @OzmosiHealth | C | · | 3 | +0.20 |
| @cfaryanoconnell | C | -0.51 | 1 | +0.00 |
| @zohmbastic | C | -1.00 | 1 | -0.15 |
| @AlertsAndNews | C | +1.52 | 1 | -0.30 |
| @OpenOutcrier | C | · | 1 | -0.35 |
| @RESERVAdeVALOR | C | +0.59 | 1 | +0.00 |
| @EmmanuelInvest | C | -1.12 | 1 | +0.40 |
Recent signals14of 14 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @Quantumup1 | +0.45 | Citizens reiterated TSHA Market Outperform-$11 after positive meeting readout. | · | tweet ↗ |
| 2026-07-02 | @EmmanuelInvest | +0.40 | Citizens reiterates Taysha Outperform with $11 PT. | · | tweet ↗ |
| 2026-07-01 | @RESERVAdeVALOR | +0.00 | Lists tickers to watch without entry intent or thesis. | · | tweet ↗ |
| 2026-06-26 | @Quantumup1 | +0.00 | Mizuho reiterated ACAD Outperform with $35 target after CHMP positive opinion. | · | tweet ↗ |
| 2026-06-25 | @OzmosiHealth | +0.15 | Taysha announces presentations highlighting TSHA-102 clinical program. | · | tweet ↗ |
| 2026-06-25 | @OpenOutcrier | -0.35 | Taysha Gene Therapies prices $200M public stock offering; down premarket. | · | tweet ↗ |
| 2026-06-24 | @AlertsAndNews | -0.30 | Taysha priced public offering of common stock and pre-funded warrants. | · | tweet ↗ |
| 2026-06-24 | @zohmbastic | -0.15 | Mentions TSHA offering and hopes for good pricing. | · | tweet ↗ |
| 2026-06-23 | @OzmosiHealth | +0.20 | Taysha will present Phase 3 Rett Syndrome results in 1H27. | · | tweet ↗ |
| 2026-06-23 | @Quantumup1 | +0.55 | BMO raises TSHA PT to $14 and reiterates Outperform after REVEAL data. | · | tweet ↗ |
| 2026-06-23 | @Quantumup1 | +0.55 | Citizens raises TSHA PT to $11 and reiterates Market Outperform after updated data. | · | tweet ↗ |
| 2026-06-22 | @Quantumup1 | +0.55 | BofA reiterates TSHA Buy and raises PO to $10 after REVEAL data. | · | tweet ↗ |
| 2026-06-22 | @cfaryanoconnell | +0.00 | Lists options with increasing implied volatility. | · | tweet ↗ |
| 2026-06-22 | @OzmosiHealth | +0.25 | Taysha completed dosing in REVEAL pivotal trial and reported longer-term data. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.